WASHINGTON -- Today, DEA served an Order to Show Cause on Truepill, a retail pharmacy that is alleged to have wrongfully filled thousands of prescriptions for stimulants used in the treatment of Attention Deficit/Hyperactivity Disorder (ADHD). Truepill was the pharmacy for telehealth companies, including Cerebral, that marketed ADHD treatments, including...

WASHINGTON – On Oct. 29, 2022, communities across the country demonstrated their continued support for DEA’s bi-annual National Prescription Drug Take Back Day by safely disposing of more than 647,000 pounds of unneeded medications at nearly 5,000 collection sites across the country. Since its inception in 2010, DEA’s National Prescription...

FRESNO, Calif. — On Oct. 20, 2022, a federal grand jury charged Sohail Mamdani, 46, of Los Banos, with mail fraud and money laundering in connection to a disability insurance fraud scheme, and unlawful use of a DEA registration number and fraudulently obtaining possession of a controlled substance, U.S. Attorney...

SACRAMENTO, Calif. — Physician Edmund Kemprud, 78, of Dublin, was convicted today of 14 counts of illegally prescribing opioids and other controlled substances patients, Acting U.S. Attorney Phillip A. Talbert announced. According to evidence presented at trial, Kemprud was a physician licensed to practice medicine in California and worked in...

WASHINGTON, DC – Today, the Drug Enforcement Administration issued a Public Safety Alert warning Americans of the alarming increase in the lethality and availability of fake prescription pills containing fentanyl and methamphetamine. DEA’s Public Safety Alert, the first in six years, seeks to raise public awareness of a significant nationwide...

WASHINGTON – The Department of Justice announced today criminal charges against 138 defendants, including 42 doctors, nurses, and other licensed medical professionals, in 31 federal districts across the United States, for their alleged participation in various healthcare fraud schemes that resulted in approximately $1.4 billion in alleged losses. The charges...

WASHINGTON – The Drug Enforcement Administration today announced an important step to improve access to medications for opioid use disorder, especially in rural areas where those suffering with opioid use disorder may have limited treatment options. Under the final rule published today, DEA registrants who are authorized to dispense methadone...

CINCINNATI – A federal grand jury has charged a pharmaceutical distributor, two of its former officials and two pharmacists with conspiring to distribute controlled substances in an indictment returned here yesterday. Four individuals have been charged, including Miami-Luken’s former president and compliance officer and two West Virginia pharmacists. Those charged...

WASHINGTON – The Drug Enforcement Administration today announced the launch of an enhanced system to help more than 1,500 registered drug manufacturers and distributors nationwide more effectively identify potential illicit drug diversion and combat the opioid epidemic. On Oct. 24, 2018, President Trump signed into law the “Substance Use–Disorder Prevention...